Ryvu Therapeutics SA (DE:9Y4)
FRANKFURT:9Y4
Rvu120
Advanced Solid Tumors, High-Risk Myelodysplastic Syndrome, Acute Myeloid Leukaemia (Aml)
Phase II
Not Yet Recruiting
RVU120 Rollover Study
May 15, 2025
―
Men1703, Glofitamab
Non-Hodgkin Lymphoma, B-Cell
Phase II
Recruiting
MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01)
Jul 30, 2024
―
Ruxolitinib, Rvu120
Myelofibrosis
Phase II
Recruiting
RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis
Apr 29, 2024
―
Rvu120 (Sel120)
Low Risk Myelodysplastic Syndromes
Phase II
Active Not Recruiting
RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms
Jan 25, 2024
―
Rvu120
Acute Myeloid Leukemia (Aml), High-Risk Myelodysplastic Syndrome
Phase II
Active Not Recruiting
Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML
Jan 05, 2024
―
Venetoclax, Rvu120
Acute Myeloid Leukemia
Phase II
Recruiting
Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML
Dec 19, 2023
―
Rvu120
Advanced Solid Tumor
Phase I/II
Active Not Recruiting
RVU120 (SEL120) in Patients with Relapse/Refractory Metastatic or Advanced Solid Tumors
Sep 07, 2021
―
Rvu120(Sel120)
Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome
Phase I
Active Not Recruiting
RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome
Jul 12, 2019
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Ryvu Therapeutics SA (9Y4) have in its pipeline
9Y4 is currently developing the following drugs: Rvu120, Men1703, Glofitamab, Ruxolitinib, Rvu120. These drug candidates are in various stages of clinical development as the company works toward FDA approval.